Understanding Autoimmune Disease: When Your Body Attacks Itself

The immune system is one of the most sophisticated systems in the human body — a vast, distributed defence network that distinguishes self from non-self and eliminates threats with extraordinary precision. But in autoimmune disease, this system turns against the body's own tissues, producing sustained inflammation and progressive organ damage. Autoimmune diseases affect an estimated 5–10% of the global population, are more common in women, and are significantly underdiagnosed in Ghana due to limited specialist access and low clinical awareness.

What Causes Autoimmune Disease?

The honest answer is that the triggers are complex and incompletely understood. A combination of genetic predisposition, environmental triggers, infections, hormonal factors, and gut microbiome disruption appear to interact in producing immune dysregulation. For many autoimmune diseases, a specific trigger event — a viral infection, a period of intense stress, a pregnancy — seems to 'unmask' underlying susceptibility in a genetically predisposed individual.

Key Blood Tests in Autoimmune Disease

ANA — Antinuclear Antibody

ANA is the primary screening test for systemic autoimmune diseases. It detects antibodies directed against components of the cell nucleus. A positive ANA is found in many autoimmune conditions including lupus (SLE), Sjögren's syndrome, scleroderma, polymyositis, and mixed connective tissue disease. However, a weakly positive ANA (titres of 1:40 or 1:80) is found in approximately 20% of healthy individuals — so a positive ANA alone does not diagnose autoimmune disease. It is the pattern and titre that matters, and further specific antibody testing is needed when ANA is positive.

Anti-dsDNA and Anti-Sm Antibodies

These are highly specific markers for systemic lupus erythematosus (SLE). Anti-dsDNA antibodies in particular correlate with lupus disease activity — rising during flares and falling during remission. SLE is significantly more common and more severe in women of African descent. It can affect virtually every organ in the body: joints, kidneys (lupus nephritis is a leading cause of kidney failure in young Ghanaian women), skin (the characteristic butterfly facial rash), heart, lungs, brain, and blood cells.

Rheumatoid Factor (RF) and Anti-CCP

Rheumatoid factor is an autoantibody against immunoglobulin G found in approximately 80% of patients with rheumatoid arthritis (RA). Anti-cyclic citrullinated peptide (anti-CCP) antibody is more specific for RA, often appearing years before clinical disease manifests. RA causes symmetric, erosive inflammation of joints — typically small joints of the hands and feet, progressing to large joints — along with systemic inflammation affecting the heart, lungs, and blood vessels. Early treatment with disease-modifying antirheumatic drugs (DMARDs) dramatically improves outcomes and prevents irreversible joint destruction.

Thyroid Antibodies — Anti-TPO and Anti-Thyroglobulin

As discussed in the thyroid post, Hashimoto's thyroiditis and Graves' disease are autoimmune in origin. Anti-thyroid peroxidase (anti-TPO) antibodies are elevated in 90–95% of Hashimoto's patients and in many Graves' patients. Testing for these antibodies helps confirm the autoimmune aetiology of thyroid dysfunction and has implications for monitoring disease progression and understanding family risk (thyroid autoimmunity runs in families).

ANCA — Anti-Neutrophil Cytoplasmic Antibodies

ANCA antibodies (c-ANCA and p-ANCA) are markers of vasculitis — inflammation of blood vessel walls. ANCA-associated vasculitides (including granulomatosis with polyangiitis, microscopic polyangiitis, and eosinophilic granulomatosis with polyangiitis) are serious conditions causing kidney failure, lung haemorrhage, and other organ-threatening complications. They are rare but should be considered in patients with unexplained kidney failure, haemoptysis, and systemic inflammation.

Complement (C3, C4)

Complement proteins are part of the innate immune system and are consumed during active autoimmune inflammation — particularly in lupus. Low C3 and C4 levels during a lupus flare indicate active immune complex-mediated inflammation and correlate with disease activity, particularly lupus nephritis.

Living With Autoimmune Disease in Ghana

The challenges are significant: specialist rheumatology care is concentrated in a few tertiary centres; many patients travel hours for appointments; disease-modifying medications are expensive and inconsistently available; and there is widespread misattribution of autoimmune symptoms to spiritual causes, leading to delays of years between symptom onset and diagnosis.

Yet outcomes can be dramatically improved with early, accurate diagnosis and access to appropriate treatment. Organisations like the Ghana Lupus Support Group are working to improve awareness and patient support. If you have unexplained joint pains, fatigue, recurrent rashes, unexplained kidney or blood abnormalities, or symptoms suggesting thyroid, lupus, or rheumatoid disease — autoimmune testing should be part of your workup.

�� Autoimmune diseases disproportionately affect women of African descent. Persistent, unexplained symptoms affecting multiple organ systems should prompt autoimmune screening — not indefinite symptom management without a diagnosis.

�� Get instant interpretation of your lab results — visit https://VincentAkwas.github.io/lablens — free, detailed clinical commentary for every value.